Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: Cancer and Leukemia Group B 9344

Journal of Clinical Oncology

Volumn 23, Issue 1, 2005, Pages 30-40

  Sartor, Carolyn I ^a   Peterson, Bercedis L ^a   Woolf, Susan ^a   FitzGerald, Thomas J ^a   Laurie, Frances ^a   Turrisi, Andrew J ^a   Bogart, Jeff ^a   Henderson, I Craig ^a   Norton, Larry ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL; AC PROTOCOL; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HUMAN; LEUKEMIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TOXICITY; TREATMENT OUTCOME; AGED; BREAST TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; ELECTIVE SURGERY; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SEGMENTAL MASTECTOMY; TUMOR RECURRENCE;

AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; RADIOTHERAPY; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, ELECTIVE;

EID: 16644401136     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.12.044     Document Type: Article

References (46)

1. Henderson IC, Berry DA, Demetri GD, et al: Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol 21:976-983, 2003
2. Harris JR, Recht A: Sequencing adjuvant chemotherapy and radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 26:183-185, 1993
3. Hartsell WF, Recine DC, Griem KL, et al: Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence. Cancer 76:2497-2503, 1995
4. Buchholz TA, Austin-Seymour MM, Moe RE, et al: Effect of delay in radiation in the combined modality treatment of breast cancer, Int J Radiat Oncol Biol Phys 26:23-35, 1993
5. Ampil FL, Burton GV, Li BD, et al: Radiotherapy with and without chemotherapy after breast conservation surgery for early stage breast cancer: A review of timing. Eur J Gynaecol Oncol 20:254-257, 1999
6. Recht A, Come SE, Henderson IC, et al: The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 334:1356-1361, 1996
7. Recht A: The return (?) of postmastectomy radiotherapy. J Clin Oncol 13:2861-2864, 1995
8. Recht A, Bartelink H, Fourquet A, et al: Postmastectomy radiotherapy: Questions for the twenty-first century. J Clin Oncol 16:2886-2889, 1998
9. Harris JR, Halpin-Murphy P, McNeese M, et al: Consensus statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys 44:989-990, 1999
10. Marks LB, Prosnitz LR: "One to three" or "four or more"? Selecting patients for postmastectomy radiation therapy. Cancer 79:668-670, 1997
11. Recht A, Edge SB, Solin LJ, et al: Post-mastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1539-1569, 2001
12. Cuzick J, Stewart H, Rutqvist L, et al: Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12:447-453, 1994
13. Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials. N Engl J Med 333:1444-1455, 1995
14. Early Breast Cancer Trialists' Collaborative Group: Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Lancet 355:1757-1770, 2000
15. Kuske RR: Adjuvant chest wall and nodal irradiation: Maximize cure, minimize late cardiac toxicity. J Clin Oncol 16:2579-2582, 1998
16. Pierce LJ, Lichter AS: Postmastectomy radiotherapy: More than locoregional control. J Clin Oncol 12:444-446, 1994
17. Recht A, Gray R, Davidson NE, et al: Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17:1689-1700, 1999
18. Milas L, Milas MM, Mason KA: Combination of taxanes with radiation: Preclinical studies. Semin Radiat Oncol 9:12-26, 1999
19. Choy H: Concurrent paclitaxel and radiation therapy in the treatment of solid tumors. Semin Radiat Oncol 9:1-3, 1999
20. Kalbfleisch J, Prentice R: The statistical analysis of failure time data. New York, NY, John Wiley and Sons, 1980
21. Fine J, Gray R: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496-509
22. Fisher B, Dignam J, Mamounas EP, et al: Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: Eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. J Clin Oncol 14:1982-1992, 1996
23. Park CC, Mitsumori M, Nixon A, et al: Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18:1668-1675, 2000
24. Buchholz TA, Tucker SL, Erwin J, et al: Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J Clin Oncol 19:2240-2246, 2001
25. Fisher B, Brown AM, Dimitrov NV, et al: Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: Results from the National Surgical Adjuvant Breast and Bowel Project B-15. J Clin Oncol 8:1483-1496, 1990
26. Wallgren A, Bernier J, Gelber RD, et al: Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer: International Breast Cancer Study Group. Int J Radiat Oncol Biol Phys. 35:649-659, 1996
27. Buzdar AU, Kau SW, Smith TL, et al: The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer. Cancer 71:3680-3684, 1993
28. Leonard CE, Wood ME, Zhen B, et al: Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control? J Clin Oncol 13:2906-2915, 1995
29. Overgaard M, Hansen PS, Overgaard J, et al: Postoperative radiotherapy in high-risk pre-menopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337:949-955, 1997
30. Overgaard M, Jensen MB, Overgaard J, et al: Postoperative radiotherapy in high-risk post-menopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353:1641-1648, 1999
31. Ragaz J, Jackson SM, Le N, et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956-962, 1997
32. Whelan TJ, Julian J, Wright J, et al: Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 18:1220-1229, 2000
33. Van de Steene J, Soete G, Storme G: Adjuvant radiotherapy for breast cancer significantly improves overall survival: The missing link. Radiother Oncol 55:263-272, 2000
34. McArdle CS, Crawford D, Dykes EH, et al: Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg 73:264-266, 1986
35. Ahmann DL, O'Fallon JR, Scanlon PW, et al: A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy. Am J Clin Oncol 5:371-381, 1982
36. Griem KL, Henderson IC, Gelman R, et al: The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol 5:1546-1555, 1987
37. Fowble B, Gray R, Gilchrist K, et al: Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol 6:1107-1117, 1988
38. Fisher B, Redmond C, Poisson R, et al: Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320:822-828, 1989
39. Fisher B, Bryant J, Wolmark N, et al: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672-2685, 1998
40. Gelman R, Gelber R, Henderson IC, et al: Improved methodology for analyzing local and distant recurrence. J Clin Oncol 8:548-555, 1990
41. Galper S, Recht A, Silver B, et al: Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone. Int J Radiat Oncol Biol Phys 45:1157-1166, 1999
42. Cuzick J, Stewart H, Peto R, et al: Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 71:15-29, 1987
43. Taghian AG, Assaad SI, Niemierko A, et al: Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst 93:1806-1811, 2001
44. Hanna YM, Baglan KL, Stromberg JS, et al: Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy. Breast J 8:149-153, 2002
45. Bellon JR, Lindsley KL, Ellis GK, et al: Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer. Int J Radiat Oncol Biol Phys 48:393-397, 2000
46. Formenti SC, Symmans WF, Volm M, et al: Concurrent paclitaxel and radiation therapy for breast cancer. Semin Radiat Oncol 9:34-42, 1999